内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Quinlan Paul T. Director active across 2 companies, notably CymaBay Therapeutics, Inc.. Aggregated, 23 disclosures have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €5m. Activity tracked since 15 May 2023. The latest transaction was disclosed on 15 September 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Quinlan Paul T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
1,039 股@ US$95.710.0016% mcap1.6% 占其流量Common StockSEC:0000907654-26-000095:0
10,000 股@ US$7.800.0011% mcap1.2% 占其流量Common StockSEC:0000907654-26-000077:0
42,000 股@ US$12.500.0073% mcap8.4% 占其流量Common StockSEC:0000907654-26-000077:1
3,630 股@ US$106.05040.0054% mcap6.1% 占其流量Common StockSEC:0000907654-26-000077:2
10,434 股@ US$107.14020.016% mcap17.8% 占其流量Common StockSEC:0000907654-26-000077:3
14,696 股@ US$107.97350.022% mcap25.3% 占其流量Common StockSEC:0000907654-26-000077:4
10,200 股@ US$109.11310.016% mcap17.7% 占其流量Common StockSEC:0000907654-26-000077:5
9,193 股@ US$110.00390.014% mcap16.1% 占其流量Common StockSEC:0000907654-26-000077:6
3,847 股@ US$111.13780.0060% mcap6.8% 占其流量Common StockSEC:0000907654-26-000077:7
733 股@ US$41.30100.0% 占其流量Common StockSEC:0000907654-26-000029:0
32,500 股0Common StockSEC:0000907654-26-000014:0
41,824 股Common StockSEC:0000950170-24-035453:0
41,824 股@ US$7.8971.3% 占其流量Common StockSEC:0001062993-24-006510:0
28,438 股0Common StockSEC:0001062993-24-001429:0
5,000 股@ US$2.943.2% 占其流量Common StockSEC:0001062993-24-000923:0
5,000 股@ US$2.943.2% 占其流量Common StockSEC:0001062993-23-022636:0
5,000 股@ US$2.943.2% 占其流量Common StockSEC:0001062993-23-021137:0
5,000 股@ US$2.943.3% 占其流量Common StockSEC:0001062993-23-019547:0
5,000 股@ US$2.9414.6% 占其流量Common StockSEC:0001062993-23-018278:0
5,000 股@ US$2.943.2% 占其流量Common StockSEC:0001062993-23-016606:0
5,000 股@ US$2.943.1% 占其流量Common StockSEC:0001062993-23-014924:0
5,000 股@ US$2.943.2% 占其流量Common StockSEC:0001062993-23-014259:0
5,000 股@ US$2.943.2% 占其流量Common StockSEC:0001062993-23-011430:0
About Quinlan Paul T
Quinlan Paul T is a declarant and holds the role of General Counsel at CymaBay Therapeutics, Inc. and Oruka Therapeutics, Inc. He has 14 filings, and across the recent filings tracked, the period runs from 2023-05-17 to 2026-03-17, with 0 in buys and 26474 in sells; the stated transaction nature is Option exercise.